|
Jan 20, 2026 |
CHURCH JEFFREY WAYNE
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 2, 2026 |
Jan 6, 2026 |
Bragg Kimberly
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 2, 2026 |
Jan 6, 2026 |
Anwer Khursheed
|
Chief Scientific Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 2, 2026 |
Jan 6, 2026 |
Fritz Frederick J.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 2, 2026 |
Jan 6, 2026 |
Faller Douglas Vincent
|
Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 2, 2026 |
Jan 6, 2026 |
Eylward Susan
|
General Counsel and Corp Sec |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 2, 2026 |
Jan 6, 2026 |
Pellizzari Christine A
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 2, 2026 |
Jan 6, 2026 |
Braun Donald P
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 2, 2026 |
Jan 6, 2026 |
Dentzer James E
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 2, 2026 |
Jan 6, 2026 |
Tardugno Michael H
|
Chair |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 2, 2026 |
Jan 6, 2026 |
Lindborg Stacy
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Sep 6, 2025 |
Sep 9, 2025 |
Lindborg Stacy
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Aug 4, 2025 |
Aug 6, 2025 |
Dentzer James E
|
Director |
Neutral |
90.0
|
+3,318
|
100.00%
|
✗
|
- |
| Aug 4, 2025 |
Aug 6, 2025 |
Pellizzari Christine A
|
Director |
Neutral |
90.0
|
+2,248
|
100.00%
|
✗
|
- |
| Aug 4, 2025 |
Aug 6, 2025 |
Braun Donald P
|
Director |
Neutral |
90.0
|
+2,040
|
119.51%
|
✗
|
- |
| Aug 4, 2025 |
Aug 6, 2025 |
Fritz Frederick J.
|
Director |
Neutral |
90.0
|
+3,161
|
402.68%
|
✗
|
- |
| Aug 4, 2025 |
Aug 6, 2025 |
Anwer Khursheed
|
Chief Scientific Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Aug 4, 2025 |
Aug 6, 2025 |
Bragg Kimberly
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Aug 4, 2025 |
Aug 6, 2025 |
Eylward Susan
|
General Counsel and Corp Sec |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Aug 4, 2025 |
Aug 6, 2025 |
Tardugno Michael H
|
Chair |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Aug 4, 2025 |
Aug 6, 2025 |
Lindborg Stacy
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Jun 17, 2025 |
Bragg Kimberly
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 14, 2024 |
Mar 18, 2025 |
Anwer Khursheed
|
Chief Scientific Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 14, 2025 |
Mar 18, 2025 |
Fritz Frederick J.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 14, 2025 |
Mar 18, 2025 |
Braun Donald P
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 14, 2025 |
Mar 18, 2025 |
Eylward Susan
|
General Counsel and Corp Sec |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 14, 2025 |
Mar 18, 2025 |
Dentzer James E
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 14, 2025 |
Mar 18, 2025 |
Tardugno Michael H
|
Chair |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 14, 2025 |
Mar 18, 2025 |
Pellizzari Christine A
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 14, 2025 |
Mar 18, 2025 |
Lindborg Stacy
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 18, 2025 |
Feb 19, 2025 |
Faller Douglas Vincent
|
Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Feb 18, 2025 |
Faller Douglas Vincent
|
Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Aug 20, 2024 |
Jan 28, 2025 |
Braun Donald P
|
Director |
Buy |
91.3
|
+25,000
|
4187.60%
|
✗
|
$29.5K |
| Dec 18, 2024 |
Dec 19, 2024 |
Tardugno Michael H
|
Chair |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Sep 6, 2024 |
Oct 31, 2024 |
Lindborg Stacy
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Oct 7, 2024 |
Oct 8, 2024 |
Eylward Susan
|
General Counsel and Corp Sec |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Oct 7, 2024 |
Eylward Susan
|
General Counsel and Corp Sec |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Sep 6, 2024 |
Sep 10, 2024 |
Braun Donald P
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Sep 6, 2024 |
Sep 10, 2024 |
Pellizzari Christine A
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Sep 6, 2024 |
Sep 10, 2024 |
Dentzer James E
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Sep 6, 2024 |
Sep 10, 2024 |
Fritz Frederick J.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Sep 6, 2024 |
Sep 10, 2024 |
Lindborg Stacy
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Sep 6, 2024 |
Sep 10, 2024 |
Tardugno Michael H
|
Chair |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Sep 6, 2024 |
Sep 10, 2024 |
Anwer Khursheed
|
Chief Scientific Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Aug 15, 2024 |
Aug 16, 2024 |
Lindborg Stacy
|
CEO |
Buy |
91.3
|
+25,000
|
10.45%
|
✗
|
$24.5K |
| Aug 15, 2024 |
Aug 16, 2024 |
Tardugno Michael H
|
Chair |
Buy |
86.3
|
+25,000
|
7.61%
|
✗
|
$25.8K |
| Jun 12, 2024 |
Jun 14, 2024 |
Tardugno Michael H
|
Chair |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 12, 2024 |
Jun 14, 2024 |
Lindborg Stacy
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 12, 2024 |
Jun 14, 2024 |
Anwer Khursheed
|
Chief Scientific Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 12, 2024 |
Jun 14, 2024 |
Fritz Frederick J.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 12, 2024 |
Jun 14, 2024 |
Pellizzari Christine A
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 12, 2024 |
Jun 14, 2024 |
Dentzer James E
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 12, 2024 |
Jun 14, 2024 |
Braun Donald P
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Jun 10, 2024 |
Gaiero David G
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 13, 2024 |
May 14, 2024 |
Lindborg Stacy
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 15, 2024 |
Mar 18, 2024 |
CHURCH JEFFREY WAYNE
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 15, 2024 |
Mar 18, 2024 |
Anwer Khursheed
|
Chief Scientific Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 15, 2024 |
Mar 18, 2024 |
Tardugno Michael H
|
Chair |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 15, 2024 |
Mar 18, 2024 |
Fritz Frederick J.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 15, 2024 |
Mar 18, 2024 |
Braun Donald P
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 15, 2024 |
Mar 18, 2024 |
Pellizzari Christine A
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 15, 2024 |
Mar 18, 2024 |
Lindborg Stacy
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 15, 2024 |
Mar 18, 2024 |
Dentzer James E
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Dec 7, 2023 |
Dec 11, 2023 |
Hazard Sebastien
|
Chief Medical Officer |
Neutral |
90.0
|
+20,000
|
100.00%
|
✗
|
- |
|
Dec 11, 2023 |
Hazard Sebastien
|
Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 17, 2023 |
Mar 21, 2023 |
Braun Donald P
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 17, 2023 |
Mar 21, 2023 |
Chow Pok Yu Augustine
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 17, 2023 |
Mar 21, 2023 |
Fritz Frederick J.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 17, 2023 |
Mar 21, 2023 |
Pellizzari Christine A
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 17, 2023 |
Mar 21, 2023 |
Dentzer James E
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 17, 2023 |
Mar 21, 2023 |
Lindborg Stacy
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 17, 2023 |
Mar 21, 2023 |
Tardugno Michael H
|
Chair |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 17, 2023 |
Mar 21, 2023 |
Anwer Khursheed
|
Chief Scientific Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 17, 2023 |
Mar 21, 2023 |
CHURCH JEFFREY WAYNE
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 17, 2023 |
Mar 21, 2023 |
Le Goff Corinne
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Sep 30, 2022 |
Oct 3, 2022 |
Dentzer James E
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Oct 3, 2022 |
Dentzer James E
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 18, 2022 |
Jul 20, 2022 |
Le Goff Corinne
|
CEO |
Neutral |
90.0
|
+53,000
|
100.00%
|
✗
|
- |
|
Jul 20, 2022 |
Le Goff Corinne
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 13, 2022 |
Jun 15, 2022 |
Kardaras Constantine John
|
Chief Accounting Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 13, 2022 |
Jun 15, 2022 |
Tumminello Timothy J
|
Controller |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 13, 2022 |
Jun 15, 2022 |
Chow Pok Yu Augustine
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 13, 2022 |
Jun 15, 2022 |
Fritz Frederick J.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 13, 2022 |
Jun 15, 2022 |
Hooper Robert W
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 13, 2022 |
Jun 15, 2022 |
Lindborg Stacy
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 13, 2022 |
Jun 15, 2022 |
Pellizzari Christine A
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 13, 2022 |
Jun 15, 2022 |
Braun Donald P
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 13, 2022 |
Jun 15, 2022 |
CHURCH JEFFREY WAYNE
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 13, 2022 |
Jun 15, 2022 |
Tardugno Michael H
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Apr 12, 2022 |
Apr 12, 2022 |
Tardugno Michael H
|
CEO |
Buy |
91.3
|
+4,000
|
31.97%
|
✗
|
$14.1K |
| Apr 8, 2022 |
Apr 11, 2022 |
Fritz Frederick J.
|
Director |
Buy |
91.3
|
+5,000
|
73.90%
|
✗
|
$20.3K |
| Mar 4, 2022 |
Mar 7, 2022 |
Tumminello Timothy J
|
Controller |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 4, 2022 |
Mar 7, 2022 |
Kardaras Constantine John
|
Chief Accounting Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 4, 2022 |
Mar 7, 2022 |
Tardugno Michael H
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 4, 2022 |
Mar 7, 2022 |
Braun Donald P
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 4, 2022 |
Mar 7, 2022 |
Lindborg Stacy
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 4, 2022 |
Mar 7, 2022 |
Pellizzari Christine A
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 4, 2022 |
Mar 7, 2022 |
Hooper Robert W
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 4, 2022 |
Mar 7, 2022 |
Chow Pok Yu Augustine
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 4, 2022 |
Mar 7, 2022 |
Fritz Frederick J.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |